Blab Tech
Quantum Cyber Acquires Bridgeport Factory, Moves HQ to Norwalk as It Shifts to Domestic Drone Production
Quantum Cyber N.V., the Nasdaq‑listed defense tech company, announced on July 16, 2026 that it had purchased a 50,000‑square‑foot industrial building at 38 Union Avenue in Bridgeport, Connecticut, for $2.3 million. The deal also saw the firm relocate its corporate headquarters from West Palm Beach, Florida, to 200 Connecticut Avenue in Norwalk, Connecticut, a move that positions the company at the heart of its new domestic manufacturing strategy.
The purchase was carried out by Quantum Cyber’s wholly‑owned Nevada subsidiary, Quantum Drones Corp. Arcade Realty LLC sold the property, while a separate $900,000 asset‑purchase agreement with Arcade Technology LLC for the metal‑stamping equipment installed on the site is still pending finalization.
In the SEC filing, CEO David Lazar said the transition “gives us the domestic production base we have said we were building, and it is the foundation from which we intend to advance toward delivering combat‑ready autonomous systems for our government customers.” He added that the Bridgeport facility will anchor the company’s move from a technology‑licensing model to a vertically integrated manufacturer.
The company, which rebranded from Mainz Biomed N.V. earlier this year, focuses on an AI‑powered “system‑of‑systems” platform that powers drone warfare, counter‑drone, and border‑security applications. Its leadership includes former U.S. Department of Veterans Affairs acting secretary Peter O’Rourke and former U.S. Department of Homeland Security assistant secretary for infrastructure protection Robert Liscouski.
Quantum Cyber’s strategy dovetails with Executive Order 14307, issued by the Trump administration to boost domestic drone production, and the Pentagon’s proposed fiscal 2027 budget, which earmarks roughly $55 billion for drone and autonomous warfare programs. Owning a U.S. manufacturing site allows the firm to meet the domestic production requirements outlined in the executive order.
The Bridgeport property covers about 1.09 acres and offers direct access to Interstate 95, a logistical advantage that could streamline supply‑chain operations. Its 50,000 square feet of floor space will house production lines, testing areas, and administrative offices.
Moving its headquarters to Norwalk places the company’s executive team and manufacturing operations in the same state, potentially easing coordination between corporate strategy and production. The new address, 200 Connecticut Avenue, is a suite in a commercial building that hosts other technology firms.
The shift to domestic manufacturing reflects a broader trend among U.S. defense contractors seeking to secure supply chains for critical technologies. The SEC filing did not disclose any financial performance data, but the purchase price and the pending equipment agreement suggest a modest capital outlay relative to the company’s overall valuation.
Quantum Cyber’s public statements emphasize that the Bridgeport facility is a concrete step toward “combat‑ready autonomous systems” for government customers. The firm has not yet announced specific product timelines or the types of drones that will be produced.
The acquisition and headquarters relocation are the latest milestones in Quantum Cyber’s transformation from a cancer‑diagnostics company to an autonomous defense technology firm. Public filings indicate that the pivot has been underway for several months, with the name change and new leadership appointments announced earlier in 2026.
Regulatory and market implications remain to be seen. While alignment with Executive Order 14307 and the Pentagon’s budget priorities could position the company favorably for future government contracts, no contracts have been disclosed. The pending metal‑stamping equipment purchase could further expand the facility’s production capabilities once closed.
In summary, Quantum Cyber has secured a U.S. manufacturing site in Bridgeport and moved its headquarters to Norwalk, Connecticut. The CEO has framed the acquisition as a foundational step toward domestic production of autonomous defense systems. The move aligns with U.S. policy priorities on domestic drone manufacturing and reflects the company’s broader strategy to transition from a licensing model to a vertically integrated manufacturer.
The company has not yet announced product launch dates, contract awards, or additional facility expansions. Future SEC filings or press releases may provide further details on production plans, equipment acquisitions, or government procurement activity.
The purchase was carried out by Quantum Cyber’s wholly‑owned Nevada subsidiary, Quantum Drones Corp. Arcade Realty LLC sold the property, while a separate $900,000 asset‑purchase agreement with Arcade Technology LLC for the metal‑stamping equipment installed on the site is still pending finalization.
In the SEC filing, CEO David Lazar said the transition “gives us the domestic production base we have said we were building, and it is the foundation from which we intend to advance toward delivering combat‑ready autonomous systems for our government customers.” He added that the Bridgeport facility will anchor the company’s move from a technology‑licensing model to a vertically integrated manufacturer.
The company, which rebranded from Mainz Biomed N.V. earlier this year, focuses on an AI‑powered “system‑of‑systems” platform that powers drone warfare, counter‑drone, and border‑security applications. Its leadership includes former U.S. Department of Veterans Affairs acting secretary Peter O’Rourke and former U.S. Department of Homeland Security assistant secretary for infrastructure protection Robert Liscouski.
Quantum Cyber’s strategy dovetails with Executive Order 14307, issued by the Trump administration to boost domestic drone production, and the Pentagon’s proposed fiscal 2027 budget, which earmarks roughly $55 billion for drone and autonomous warfare programs. Owning a U.S. manufacturing site allows the firm to meet the domestic production requirements outlined in the executive order.
The Bridgeport property covers about 1.09 acres and offers direct access to Interstate 95, a logistical advantage that could streamline supply‑chain operations. Its 50,000 square feet of floor space will house production lines, testing areas, and administrative offices.
Moving its headquarters to Norwalk places the company’s executive team and manufacturing operations in the same state, potentially easing coordination between corporate strategy and production. The new address, 200 Connecticut Avenue, is a suite in a commercial building that hosts other technology firms.
The shift to domestic manufacturing reflects a broader trend among U.S. defense contractors seeking to secure supply chains for critical technologies. The SEC filing did not disclose any financial performance data, but the purchase price and the pending equipment agreement suggest a modest capital outlay relative to the company’s overall valuation.
Quantum Cyber’s public statements emphasize that the Bridgeport facility is a concrete step toward “combat‑ready autonomous systems” for government customers. The firm has not yet announced specific product timelines or the types of drones that will be produced.
The acquisition and headquarters relocation are the latest milestones in Quantum Cyber’s transformation from a cancer‑diagnostics company to an autonomous defense technology firm. Public filings indicate that the pivot has been underway for several months, with the name change and new leadership appointments announced earlier in 2026.
Regulatory and market implications remain to be seen. While alignment with Executive Order 14307 and the Pentagon’s budget priorities could position the company favorably for future government contracts, no contracts have been disclosed. The pending metal‑stamping equipment purchase could further expand the facility’s production capabilities once closed.
In summary, Quantum Cyber has secured a U.S. manufacturing site in Bridgeport and moved its headquarters to Norwalk, Connecticut. The CEO has framed the acquisition as a foundational step toward domestic production of autonomous defense systems. The move aligns with U.S. policy priorities on domestic drone manufacturing and reflects the company’s broader strategy to transition from a licensing model to a vertically integrated manufacturer.
The company has not yet announced product launch dates, contract awards, or additional facility expansions. Future SEC filings or press releases may provide further details on production plans, equipment acquisitions, or government procurement activity.
